(4-(Bromomethyl)phenyl)(phenyl)methanone, 95.0%, 25g

N-(Methoxymethyl)acrylamide (stabilized with MEHQ)>95.0%(GC)(T)25g

tert-Butyl (3R,4S)-4-fluoro-3-hydroxypiperidine-1-carboxylate, 98%, 1g

2-Methyl-5-(pyridin-2-yl)aniline, 95%, 50mg

5-(4-Fluorophenyl)-1,3,4-oxadiazole-2-carboxylic acid, 98%, 1g

3,4-DICHLORO-2,5-DIHYDRO-1H-PYRROLE-2,5-DIONE, 95.0%, 1g

1-Nitro-2-naphthol>98.0%(GC)(T)5g

1-tert-butyl-4-[(methylamino)methyl]pyrrolidin-2-one, 95.0%, 1g

(3S,4S)-1-Benzyl-N,4-dimethylpiperidin-3-amine, 97%, 100mg

(R)-methyl 5-(2-nitro-5-(pivaloyloxymethyl)phenylamino)-3-(1-(2-(trifluoromethyl)phenyl)ethoxy)thiophene-2-carboxylate, 95%, 100mg

(2S,3S)-2,3-Dimethoxy-N1,N1,N4,N4-tetramethylbutane-1,4-diamine, 97.0%, 1g

Balance de table série FKB, 0,05 g, 16000 g, FKB 16K0.05

(Perfluorohexyl)phenyliodonium Trifluoromethanesulfonate>98.0%(T)1g